发明名称 |
Use of truncated cysteine IL28 and IL29 Mutants to treat cancers and autoimmune disorders |
摘要 |
Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics. |
申请公布号 |
US8313739(B2) |
申请公布日期 |
2012.11.20 |
申请号 |
US201113042210 |
申请日期 |
2011.03.07 |
申请人 |
SHEPPARD PAUL O.;ZYMOGENETICS, INC. |
发明人 |
SHEPPARD PAUL O. |
分类号 |
A61K38/19;A61K45/00 |
主分类号 |
A61K38/19 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|